These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The changing concept of hypernephroma. Warren MM; Kelalis PP; Utz DC J Urol; 1970 Sep; 104(3):376-9. PubMed ID: 5459969 [No Abstract] [Full Text] [Related]
12. [A case od cancer of the kidney with long-term erythrocytosis]. Nesterenko AO; Goriachev IA; Kukushkin AV; Simonenko VB; Popik GV; Kuznetsov MS Klin Med (Mosk); 1989 Nov; 67(11):126-8. PubMed ID: 2625947 [No Abstract] [Full Text] [Related]
13. Serum haptoglobin: a nonspecific tumor marker for renal cell carcinoma. Babaian RJ; Swanson DA South Med J; 1982 Nov; 75(11):1345-8. PubMed ID: 7146964 [TBL] [Abstract][Full Text] [Related]
14. Reversible non-metastatic liver-cell dysfunction and thrombocytosis from a hypernephroma. Mohamed SD Lancet; 1965 Sep; 2(7413):621-3. PubMed ID: 4157563 [No Abstract] [Full Text] [Related]
15. Atypical erythema multiforme--a marker of malignancy? Report of a case occurring with renal cell carcinoma. Davidson DM; Jegasothy BV Cutis; 1980 Sep; 26(3):276-8. PubMed ID: 7428430 [TBL] [Abstract][Full Text] [Related]
16. [Cases of renal carcinoma simulating systemic hemopathies. Differential diagnostic considerations on the "systemic" manifestations of certain cases of renal carcinoma]. Storti E; Torelli U; Quaglino D Minerva Med; 1966 Oct; 57(82):3321-8. PubMed ID: 5927135 [No Abstract] [Full Text] [Related]